A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of JNJ-42160443 with
placebo in the treatment of chronic, moderate to severe cancer-related pain in terminally ill
patients with a diagnosis of active cancer.